Howden et al., 1990 - Google Patents
Liver preservation with UW solution: I. Evidence that hydroxyethyl starch is not essentialHowden et al., 1990
- Document ID
- 15697964860069015280
- Author
- Howden B
- Jablonski P
- Thomas A
- Walls K
- Biguzas M
- Scott D
- Grossman H
- Marshall V
- Publication year
- Publication venue
- Transplantation
External Links
Snippet
Preservation of rat livers by simple ice-storage has been demonstrated after 24 hr using the University of Wisconsin (UW) solution. Equally good preservation could be obtained by substituting hydroxyethyl starch (HES) from another source or by omission of HES from the …
- 238000004321 preservation 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
- A01N1/0247—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components for perfusion, i.e. for circulating fluid through organs, blood vessels or other living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Howden et al. | Liver preservation with UW solution: I. Evidence that hydroxyethyl starch is not essential | |
| SUMIMOTO et al. | 24-hour rat liver preservation using UW solution and some simplified variants | |
| KR950015064B1 (en) | Solution for the preservation of organs | |
| ROWLEY | Hematopoietic stem cell cryopreservation: a review of current techniques | |
| US5145771A (en) | Rinse solution for organs and tissues | |
| US5370989A (en) | Solution for prolonged organ preservation | |
| US5200398A (en) | Composition for the preservation of organs comprising glucuronic acid or a physiologically tolerated salt or ester thereof | |
| Biguzas et al. | EVALUATION OF UW SOLUTION IN A RAT KIDNEY PRESERVATION MODEL: I. EFFECT OF HYDROXYETHYL STARCH AND ELECTROLYTE COMPOSITION | |
| EP0713363B1 (en) | Rinse solution for organs and tissues | |
| Dempster et al. | Simple kidney-storage technique | |
| Florack et al. | Definition of normothermic ischemia limits for kidney and pancreas grafts | |
| Tersigni et al. | Pancreaticoduodenal preservation by hypothermic pulsatile perfusion for twenty-four hours | |
| Toledo-Pereyra et al. | Forty-eight hours hypothermic storage of whole canine pancreas allografts. Improved preservation with a colloid hyperosmolar solution | |
| Schemmer et al. | Taurine improves graft survival after experimental liver transplantation | |
| Thurman et al. | Role of sinusoidal lining cells in hepatic reperfusion injury following cold storage and transplantation | |
| US5660976A (en) | Method for preserving a liver by perfusion with or storage in a solution containing ascorbyl tocopheryl phosphodiester | |
| Todo et al. | Comparison of UW with other solutions for liver preservation in dogs | |
| Serrick et al. | Amelioration of pulmonary allograft injury by administering a second rinse solution | |
| US5556842A (en) | Method for viable preservation of lung grafts | |
| Kurzawinski et al. | A prospective randomized clinical trial of liver preservation using high‐odium versus high‐potassium lactobionate/raffinose solution | |
| Sundberg et al. | Effects of chlorpromazine and methylprednisolone on perfusion preservation of rabbit livers | |
| KR100304594B1 (en) | Composition for the Preservation of Organs and Blood Cells | |
| KAROW JR et al. | FUNCTIONAL PRESERVATION OF THE MAMMALIAN KIDNEY: VII. AUTOLOGOUS TRANSPLANTATION OF DOG KIDNEYS AFTER TREATMENT WITH DIMETHYLSULFOXIDE (2.8 AND 4.2 M) | |
| EGAwA et al. | SIGNIFICANCE OF TERMINAL RINSE FOR RAT LIVER PRESERVATION1 | |
| Takeuchi et al. | Prolonged preservation of the blood-perfused canine heart with glycolysis-promoting solution |